Insider Transactions in Q2 2022 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2022
|
Keith A. Goldan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,205
+50.0%
|
-
|
|
Apr 04
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
3,128
-14.92%
|
$56,304
$18.29 P/Share
|
|
Apr 04
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
3,128
+12.98%
|
$31,280
$10.9 P/Share
|
|
Apr 01
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
101,045
-50.03%
|
$1,717,765
$17.45 P/Share
|
|
Apr 01
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
70,545
+44.39%
|
$705,450
$10.9 P/Share
|